checkAd
    Provectus Biopharmaceuticals Aktie
    0,1700
     
    USD
    -3,31 %
    -0,0058 USD
    Letzter Kurs 02:10:00 Nasdaq OTC
    ISIN: US74373P1084 · WKN: A1XCTC · SYM: PVCT · USA

    Neueste Nachrichten

    Provectus Biopharmaceuticals Announces Poster Presentation of Rose Bengal Sodium for Treatment of Full-Thickness Cutaneous Wounds at SID 2024 Annual Meeting
    21.05.24 · globenewswire · Provectus Biopharmaceuticals
    Provectus Biopharmaceuticals Announces Eight Presentations of Rose Bengal Photodynamic Antimicrobial Therapy at ARVO 2024 Annual Meeting
    14.05.24 · globenewswire · Provectus Biopharmaceuticals
    Provectus Biopharmaceuticals Announces Notice of Allowance for U.S. Patent of Oral Administration of Rose Bengal Sodium in Hematology (Leukemia)
    02.05.24 · globenewswire · Provectus Biopharmaceuticals
    Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose Bengal for Solid Tumor Cancers
    18.04.24 · globenewswire · Provectus Biopharmaceuticals
    Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
    16.04.24 · globenewswire · Provectus Biopharmaceuticals
    Provectus Biopharmaceuticals Announces Presentation of Cancer Immunotherapy PV-10 Poster for HNSCC at AACR 2024 Annual Meeting
    11.04.24 · globenewswire · Provectus Biopharmaceuticals
    Provectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miami for Photodynamic Antimicrobial Treatment of Different Eye Infections with Rose Bengal Sodium
    27.03.24 · globenewswire · Provectus Biopharmaceuticals
    Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines
    12.03.24 · globenewswire · Provectus Biopharmaceuticals
    Provectus Biopharmaceuticals Announces Acceptance of Cancer Immunotherapy PV-10 Abstract for HNSCC at AACR 2024 Annual Meeting
    07.03.24 · globenewswire · Provectus Biopharmaceuticals
    Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual Meeting
    29.02.24 · globenewswire · Provectus Biopharmaceuticals
    Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
    15.02.24 · globenewswire · Provectus Biopharmaceuticals
    Provectus Biopharmaceuticals Engages irlabs for Investor Relations Services
    14.02.24 · globenewswire · Provectus Biopharmaceuticals